AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Taro Receives FDA Approval for Clotrimazole and Betamethasone Dipropionate Lotion ANDA; Generic Equivalent to Lotrisone Lotion.

Business Wire

| July 29, 2004 | COPYRIGHT 2004 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

HAWTHORNE, N.Y. -- Taro Pharmaceutical Industries Ltd. (Nasdaq: TARO) reported today that its U.S. affiliate has received approval from the U.S. Food and Drug Administration ("FDA") for its Abbreviated New Drug Application ("ANDA") for clotrimazole and betamethasone dipropionate lotion ("C/B lotion").

Taro's C/B lotion is bioequivalent to Schering's Lotrisone(R) lotion. C/B lotion is a combination topical corticosteroid and antifungal product available by prescription only. It is used to treat inflammatory fungal infections of the skin, including athlete's foot. According to industry sources, U.S. sales of Lotrisone(R) lotion were approximately $39 million in 2003.

Currently, Taro has 31 filings at the FDA: 30 ANDAs, including tentative approvals for fluconazole tablets and loratadine syrup, plus one New Drug Application related to the Company's NonSpil(TM) liquid drug delivery system. In addition, the Company has multiple regulatory filings in Canada, Israel and other countries.

Taro is a multinational, science-based pharmaceutical company, dedicated to meeting the needs of its customers through the discovery, development, manufacturing and marketing of the highest quality healthcare products.

For further information on Taro ...

Related articles from newspapers, magazines, journals, and more
(OTC:TAROF) Taro Pharmaceutical Industries, Ltd. just released some important...
Press release article from: M2 Presswire June 23, 2008 700+ words
...com: (OTC:TAROF) Taro Pharmaceutical Industries, Ltd. just released...23062008 (OTC:TAROF) Taro Pharmaceutical Industries, Ltd.- Taro Receives...for (OTC:TAROF) Taro Pharmaceutical Industries, Ltd., has been...
Taro Pharmaceutical Industries Reports Record First Quarter Sales and Earnings.
Press release article from: Business Wire April 18, 2000 700+ words
...Vaginal Cream 2% in April 2000 Taro Pharmaceutical Industries Ltd. (Nasdaq/NMS:TARO) today...exceeding $1.5 billion. About Taro Pharmaceutical Industries Ltd. Taro Pharmaceutical Industries Ltd. is a multinational, science...
Taro Pharmaceutical Industries announces Israel Ministry of Health approvals of...
Press release article from: Business Wire September 24, 1996 700+ words
...Sept. 24, 1996--Taro Pharmaceutical Industries Ltd. (NASDAQ/NMS...D., chairman of Taro Pharmaceutical Industries. "The significance...delivery systems." Taro Pharmaceutical Industries, a manufacturer and...
Sun Pharma acquires Israeli pharma producer.(GENERIC DRUGS)(Sun Pharmaceutical...
Magazine article from: Chemical Week Ramesh, Deepti May 30, 2007 700+ words
Sun Pharmaceutical Industries (Sun Pharma; Mumbai), a pharmaceuticals company, says it has agreed to acquire generic drugs manufacturer Taro Pharmaceutical Industries (Haifa, Israel) in an all-cash deal worth $454 million...
Event Brief of Q4 2004 Taro Pharmaceutical Industries Earnings Conference Call...
News wire article from: The America's Intelligence Wire February 24, 2005 700+ words
...PARTICIPANTS . Daniel Saks, Taro Pharmaceutical Industries, VP - Corporate Affairs & IR . Barrie Levitt, Taro Pharmaceutical Industries, Chairman . Kevin Connelly, Taro Pharmaceutical Industries, CFO OVERVIEW Company reported...
Event Brief of Q3 2004 Taro Pharmaceutical Industries Earnings Conference Call...
News wire article from: Fair Disclosure Wire October 28, 2004 700+ words
...PARTICIPANTS . Daniel Saks, Taro Pharmaceutical Industries, VP,Corporate Affairs . Barrie Levitt, Taro Pharmaceutical Industries, Chairman . Kevin Connelly, Taro Pharmaceutical Industries, CFO OVERVIEW TARO reports...
Event Brief of Q1 2004 Taro Pharmaceutical Industries Earnings Conference Call...
News wire article from: The America's Intelligence Wire April 29, 2004 700+ words
...PARTICIPANTS . Daniel Saks, Taro Pharmaceutical Industries Ltd., VP, Corporate...Dr. Barrie Levitt, Taro Pharmaceutical Industries Ltd., Chairman . Kevin Connelly, Taro Pharmaceutical Industries Ltd., CFO OVERVIEW...
Event Brief of Q4 2003 Taro Pharmaceutical Industries Earnings Conference Call...
News wire article from: The America's Intelligence Wire February 17, 2004 700+ words
...PARTICIPANTS . Daniel Saks, Taro Pharmaceutical Industries Ltd., VP, Corporate...Affairs . Barrie Levitt, Taro Pharmaceutical Industries Ltd., Chairman . Kevin Connelly, Taro Pharmaceutical Industries Ltd., CFO OVERVIEW...
Event Brief of Q3 2003 Taro Pharmaceutical Industries Earnings Conference Call...
News wire article from: Fair Disclosure Wire October 30, 2003 700+ words
...PARTICIPANTS . Daniel Saks, Taro Pharmaceutical Industries Ltd., VP - Corporate...Affairs . Barrie Levitt, Taro Pharmaceutical Industries Ltd., Chairman . Kevin Connelly, Taro Pharmaceutical Industries Ltd., CFO OVERVIEW...
Event Brief of Q2 2005 Taro Pharmaceutical Industries Earnings Conference Call...
News wire article from: Fair Disclosure Wire July 28, 2005 700+ words
...PARTICIPANTS . Daniel Saks, Taro Pharmaceutical Industries Ltd., VP, Corporate...Affairs . Barrie Levitt, Taro Pharmaceutical Industries Ltd., Chairman . Kevin Connelly, Taro Pharmaceutical Industries Ltd., CFO OVERVIEW...
For more facts and information, see all results

Source: HighBeam Research, Taro Receives FDA Approval for Clotrimazole and Betamethasone...

©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA